MANNITOL Inf.-Lsg. 15, 10X250 ml

Instructions for use for MANNITOL Inf.-Lsg. 15, 10X250 ml

Directions for use of the article MANNITOL INFUSIONSLOE 15: - MANNITOL-INFUSIONSLÖSUNG 15 contains 150 g mannitol per litre, water for injection and a 33% sodium hydroxide solution. It is used for the therapy and prophylaxis of acute renal failure, for lowering intracranial pressure when the blood-brain barrier is intact, for osmotherapy in cerebral oedema, for the treatment of glaucoma, for the initiation of osmotic diuresis in oliguria/anuria and for the diagnosis of oliguria/anuria. - No treatment should be given for persistent oliguria/anuria after a trial infusion, cardiac decompensation, dehydration, pulmonary oedema, intracranial haemorrhage, hyperhydration, blood-brain barrier disorders and increased serum osmolarity. Use during pregnancy and lactation should only be undertaken after careful risk-benefit assessment. - Possible side effects are an increase in serum osmolarity, excess of extracellular fluid, decrease in haemoglobin and haematocrit, decrease in serum electrolytes, exchange of potassium from the cell into the extracellular space, hypersensitivity reactions up to and including shock, Water loss with dehydration, electrolyte loss, headache, convulsions, acute volume stress of the cardio-circulatory system, tachycardia, pulmonary oedema with impaired renal function, nausea with vomiting, upper abdominal discomfort and confusional states. - It is important to read the package leaflet and ask your doctor or pharmacist for advice to understand possible risks and side effects. - MANNITOL INFUSIONSLOE 15 is available only from pharmacies and from the manufacturer Serumwerk Bernburg AG.